Lupus skin treatment trial halted after low enrollment

NCT ID NCT05879718

Summary

This study tested an experimental drug called PF-06823859 for adults with lupus who have active skin symptoms. The goal was to see if the drug could reduce skin inflammation and improve symptoms compared to a placebo. The trial was terminated early after enrolling only 8 participants, far fewer than the planned 48.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cleveland Clinic Foundation

    Cleveland, Ohio, 44195, United States

  • DermEffects

    London, Ontario, N6H 5L5, Canada

  • Dermatological and Venereological Hospital Andreas Syggros

    Athens, 161 21, Greece

  • Dermatology Research Associates

    Los Angeles, California, 90045, United States

  • Dermatology on Bloor - Research Toronto

    Toronto, Ontario, M4W 2N4, Canada

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Hospital Universitario 12 de Octubre

    Madrid, 28041, Spain

  • Hospital Universitario Virgen Del Rocio

    Seville, 41013, Spain

  • Ionos Dragoumi 5 Kaisariani

    Kaisarianí, Attikí, 16121, Greece

  • Mayo Clinic Hospital

    Phoenix, Arizona, 85054, United States

  • Mayo Clinic in Arizona - Scottsdale

    Scottsdale, Arizona, 85259, United States

  • The Kirklin Clinic of UAB Hospital

    Birmingham, Alabama, 35233, United States

  • The University of Alabama at Birmingham

    Birmingham, Alabama, 35249, United States

  • The University of Kansas Hospital

    Kansas City, Kansas, 66160, United States

  • University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA"

    Chaïdári, Attikí, 124 62, Greece

  • University of Alabama at Birmingham - School of Medicine

    Birmingham, Alabama, 35233, United States

  • University of Alabama at Birmingham, Department of Dermatology

    Birmingham, Alabama, 35233, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • Whitby Health Centre

    Whitby, Ontario, L1P 0p9, Canada

Conditions

Explore the condition pages connected to this study.